GW Pharma (GWPH): Most Likely Outcome of AES Meeting is $10 Upside, But Smaller Chance for Downside Pressure - Morgan Stanley

November 30, 2016 9:29 AM EST Send to a Friend
Morgan Stanley analyst Andrew Berens weighed in on GW Pharma (NASDAQ: GWPH) ahead of data releases this weekend at the ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login